Related Experiment Video
Updated: Mar 21, 2026

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
What goes around comes around: novel pharmacological targets in the gut-brain axis
Camila González-Arancibia1, Jorge Escobar-Luna1, Camila Barrera-Bugueño1
1Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
Abstract:
The gut and the brain communicate bidirectionally through anatomic and humoral pathways, establishing what is known as the gut-brain axis. Therefore, interventions affecting one system will impact on the other, giving the opportunity to investigate and develop future therapeutic strategies that target both systems. Alterations in the gut-brain axis may arise as a consequence of changes in microbiota composition (dysbiosis), modifications in intestinal barrier function, impairment of enteric nervous system, unbalanced local immune response and exaggerated responses to stress, to mention a few. In this review we analyze and discuss several novel pharmacological targets within the gut-brain axis, with potential applications to improve intestinal and mental health.
Related Concept Videos
Gut-Brain Axis
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Physiology of Enteric Nervous System and Gut Health
Neural Regulation
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Enteric Nervous System: Regulation of GI Motor Activity
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...

